BC Cancer - Surrey

13750 96th Avenue
Surrey, BC, V3V 1Z2

Clinical Trial Unit Manager
Nicole Valade
604-319-8067
nicole.valade@bccancer.bc.ca

Gynecological

Non-Randomized, Open-Label Phase II Study to Assess Olaparib Tablets as a Treatment for Subjects with Different HRD Tumor Status and with Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That Have Received at Least 2 Prior Lines of Chemotherapy

Cancer Type
Gynecological
Phase II
Recruiting Dates
BC Cancer - Surrey
Open Recruiting Date
View on ClinicalTrials.gov
Back to top